A novel drug for activated phosphoinositide-3 kinase delta syndrome: Leniolisib February 6, 2025adminUncategorized Read more
Basic information of 50 new molecular entities approved by the FDA in 2024 February 2, 2025adminArticles Read more
Ways You Can Reinvent Celebrity Without Looking Like Amateur August 12, 2022adminUncategorized Read more
A novel drug for activated phosphoinositide-3 kinase delta syndrome: Leniolisib February 6, 2025adminUncategorized Read more
Ways You Can Reinvent Celebrity Without Looking Like Amateur August 12, 2022adminUncategorized Read more
Drugs Beta selective blocking agent: Landiolol February 22, 2025admin Product information: Active name: LANDIOLOL HYDROCHLORIDE Brand name: RAPIBLYK Innovator name AOP ORPHAN PHARMACEUTICALS AG…
Drugs Iodine based contrasting agent: IOMEPROL February 22, 2025admin IOMEPROL: Active name: IOMEPROL Brand name: IOMERVU Innovator name BRACCO DIAGNOSTICS INC Approval Date: NOV…
Drugs ALK Rearranged lung cancer: Ensartinib February 8, 2025admin Active name: ENSARTINIB HYDROCHLORIDE Brand name: ENSACOVE Innovator name XCOVERY HOLDINGS INC Approval Date: Dec…
Drugs Treatment of cystic fibrosis: Vanzacaftor February 8, 2025admin Active name: Vanzacaftor calcium dihydrate Brand name: ALYFTREK Innovator name VERTEX PHARMACEUTICALS INC Approval Date:…